Gornitzky represented the sole underwriter, Ladenburg Thalmann, in RedHill Biopharma’s USD 25 million underwritten public offering of American Depositary Shares (ADSs) on the NASDAQ Global Market.
RedHill Biopharma Ltd., a biopharmaceutical company primarily focused on the development and commercialization of proprietary drugs for the treatment of gastrointestinal diseases, is dually traded on the NASDAQ and the Tel Aviv Stock Exchange (NASDAQ: RDHL, TASE: RDHL).
Ladenburg Thalmann acted as sole book-running manager for the offering.
Ladenburg Thalmann was represented by Chaim Friedland (Partner), Ari Fried (Partner), Nir Knoll (Associate) and Netanel Kahane (Associate).
